Article

jdsupra.comjdsupra.com on 2017-08-28 23:29

FDA Approves Boehringer Ingelheim’s Adalimumab Biosimilar

Today, Boehringer Ingelheim received FDA approval for Cyltezo®, its biosimilar to AbbVie’s Humira® (adalimumab). Cyltezo® is approved for the ...

Related news